NASDAQ:ELDN | Insider Transactions | Eledon Pharmaceuticals, Inc.

ELDN Insider Transactions

130 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.

ELDN insiders transaction timeline

PurchaseSale
2014-06-15: 2 sales — NOVARTIS AG, Novartis Bioventures Ltd2014-09-22: 5 purchases — Satter Muneer A, Apple Tree Partners II - Annex, L.P., Harrison Seth Loring and 2 more2015-03-18: 2 sales — NOVARTIS AG, Novartis Bioventures Ltd2015-03-19: 2 sales — NOVARTIS AG, Novartis Bioventures Ltd2015-04-02: 1 sale — Kalowski Lee2015-04-16: 1 sale — Kalowski Lee2015-06-11: 2 sales — NOVARTIS AG, Novartis Bioventures Ltd2015-06-12: 2 sales — NOVARTIS AG, Novartis Bioventures Ltd2015-06-16: 2 sales — NOVARTIS AG, Novartis Bioventures Ltd2015-06-22: 1 sale — McBride John S.2015-06-23: 1 sale — McBride John S.2015-06-24: 1 sale — McBride John S.2015-06-26: 1 sale — Morrison Jodie Pope2015-06-29: 1 sale — Morrison Jodie Pope2015-07-13: 2 sales — NOVARTIS AG, Novartis Bioventures Ltd2015-07-14: 2 sales — NOVARTIS AG, Novartis Bioventures Ltd2015-07-15: 2 sales — NOVARTIS AG, Novartis Bioventures Ltd2015-07-28: 1 sale — Morrison Jodie Pope2015-07-29: 1 sale — Morrison Jodie Pope2015-09-02: 1 sale — Kalowski Lee2015-09-08: 1 sale — Kalowski Lee2015-09-21: 1 sale — McBride John S.2015-11-11: 1 purchase — Buckley Stephen Jr.2016-03-15: 1 purchase — Buckley Stephen Jr.2017-05-10: 3 purchases — FLESHER GREGORY J., TURKEL CATHERINE C., OCAMPO CHRISTINE2018-09-05: 1 purchase — TURKEL CATHERINE C.2018-09-11: 1 purchase — TURKEL CATHERINE C.2018-09-12: 1 purchase — TURKEL CATHERINE C.2019-04-30: 2 sales — LIFESCI INDEX PARTNERS LLC, YOOK PAUL2019-05-02: 3 purchases — OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership, Chimovits Erez2019-05-20: 3 sales — TURKEL CATHERINE C., Kuwahara Jon, FLESHER GREGORY J.2019-05-21: 3 sales — TURKEL CATHERINE C., Kuwahara Jon, FLESHER GREGORY J.2020-10-30: 7 purchases — Logos Global Management LP2020-10-30: 2 sales — Logos Global Management LP2020-12-02: 2 sales — OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership2021-06-09: 1 purchase — Gros David-Alexandre C2021-06-11: 1 purchase — Little Paul Sean2021-08-17: 1 purchase — Gros David-Alexandre C2021-12-20: 1 purchase — Gros David-Alexandre C2022-11-23: 1 purchase — Perrin Steven2023-05-05: 30 purchases — BIOTECHNOLOGY VALUE FUND L P, BVF PARTNERS L P/IL, BVF INC/IL and 7 more2024-05-09: 30 purchases — BIOTECHNOLOGY VALUE FUND L P, BVF PARTNERS L P/IL, BVF INC/IL and 7 more2014-06-152024-05-09
Insider profileRoleDateTransactionSharesPrice
BIOTECHNOLOGY VALUE FUND L POther2024-05-09Purchase75,431.0
BVF PARTNERS L P/ILTenPercentOwner2024-05-09Purchase75,431.0
BVF INC/ILTenPercentOwner2024-05-09Purchase75,431.0
BIOTECHNOLOGY VALUE FUND II LPOther2024-05-09Purchase75,431.0
LAMPERT MARK NTenPercentOwner2024-05-09Purchase75,431.0
Biotechnology Value Trading Fund OS LPOther2024-05-09Purchase75,431.0
BVF Partners OS Ltd.Other2024-05-09Purchase75,431.0
BVF I GP LLCOther2024-05-09Purchase75,431.0
BVF II GP LLCOther2024-05-09Purchase75,431.0
BVF GP HOLDINGS LLCTenPercentOwner2024-05-09Purchase75,431.0
BIOTECHNOLOGY VALUE FUND L POther2024-05-09Purchase821,121.0
BVF PARTNERS L P/ILTenPercentOwner2024-05-09Purchase821,121.0
BVF INC/ILTenPercentOwner2024-05-09Purchase821,121.0
BIOTECHNOLOGY VALUE FUND II LPOther2024-05-09Purchase821,121.0
LAMPERT MARK NTenPercentOwner2024-05-09Purchase821,121.0
Biotechnology Value Trading Fund OS LPOther2024-05-09Purchase821,121.0
BVF Partners OS Ltd.Other2024-05-09Purchase821,121.0
BVF I GP LLCOther2024-05-09Purchase821,121.0
BVF II GP LLCOther2024-05-09Purchase821,121.0
BVF GP HOLDINGS LLCTenPercentOwner2024-05-09Purchase821,121.0
BIOTECHNOLOGY VALUE FUND L POther2024-05-09Purchase1,031,385.0
BVF PARTNERS L P/ILTenPercentOwner2024-05-09Purchase1,031,385.0
BVF INC/ILTenPercentOwner2024-05-09Purchase1,031,385.0
BIOTECHNOLOGY VALUE FUND II LPOther2024-05-09Purchase1,031,385.0
LAMPERT MARK NTenPercentOwner2024-05-09Purchase1,031,385.0
Biotechnology Value Trading Fund OS LPOther2024-05-09Purchase1,031,385.0
BVF Partners OS Ltd.Other2024-05-09Purchase1,031,385.0
BVF I GP LLCOther2024-05-09Purchase1,031,385.0
BVF II GP LLCOther2024-05-09Purchase1,031,385.0
BVF GP HOLDINGS LLCTenPercentOwner2024-05-09Purchase1,031,385.0
BIOTECHNOLOGY VALUE FUND L POther2023-05-05Purchase86,341.0
BVF PARTNERS L P/ILTenPercentOwner2023-05-05Purchase86,341.0
BVF INC/ILTenPercentOwner2023-05-05Purchase86,341.0
BIOTECHNOLOGY VALUE FUND II LPOther2023-05-05Purchase86,341.0
LAMPERT MARK NTenPercentOwner2023-05-05Purchase86,341.0
Biotechnology Value Trading Fund OS LPOther2023-05-05Purchase86,341.0
BVF Partners OS Ltd.Other2023-05-05Purchase86,341.0
BVF I GP LLCOther2023-05-05Purchase86,341.0
BVF II GP LLCOther2023-05-05Purchase86,341.0
BVF GP HOLDINGS LLCTenPercentOwner2023-05-05Purchase86,341.0
BIOTECHNOLOGY VALUE FUND L POther2023-05-05Purchase837,146.0
BVF PARTNERS L P/ILTenPercentOwner2023-05-05Purchase837,146.0
BVF INC/ILTenPercentOwner2023-05-05Purchase837,146.0
BIOTECHNOLOGY VALUE FUND II LPOther2023-05-05Purchase837,146.0
LAMPERT MARK NTenPercentOwner2023-05-05Purchase837,146.0
Biotechnology Value Trading Fund OS LPOther2023-05-05Purchase837,146.0
BVF Partners OS Ltd.Other2023-05-05Purchase837,146.0
BVF I GP LLCOther2023-05-05Purchase837,146.0
BVF II GP LLCOther2023-05-05Purchase837,146.0
BVF GP HOLDINGS LLCTenPercentOwner2023-05-05Purchase837,146.0
BIOTECHNOLOGY VALUE FUND L POther2023-05-05Purchase1,055,445.0
BVF PARTNERS L P/ILTenPercentOwner2023-05-05Purchase1,055,445.0
BVF INC/ILTenPercentOwner2023-05-05Purchase1,055,445.0
BIOTECHNOLOGY VALUE FUND II LPOther2023-05-05Purchase1,055,445.0
LAMPERT MARK NTenPercentOwner2023-05-05Purchase1,055,445.0
Biotechnology Value Trading Fund OS LPOther2023-05-05Purchase1,055,445.0
BVF Partners OS Ltd.Other2023-05-05Purchase1,055,445.0
BVF I GP LLCOther2023-05-05Purchase1,055,445.0
BVF II GP LLCOther2023-05-05Purchase1,055,445.0
BVF GP HOLDINGS LLCTenPercentOwner2023-05-05Purchase1,055,445.0
Perrin StevenPresident2022-11-23Purchase1,000.0$2.6
Gros David-Alexandre CChief Executive Officer2021-12-20Purchase2,000.0$4.48
Gros David-Alexandre CChief Executive Officer2021-08-17Purchase4,000.0$6.21
Little Paul SeanCHIEF FINANCIAL OFFICER2021-06-11Purchase10,000.0$8.87
Gros David-Alexandre CChief Executive Officer2021-06-09Purchase3,000.0$8.01
OrbiMed Israel GP Ltd.TenPercentOwner2020-12-02Sale103,200.0$21.6
OrbiMed Israel BioFund GP Limited PartnershipTenPercentOwner2020-12-02Sale103,200.0$21.6
Logos Global Management LPTenPercentOwner2020-10-30Purchase9,098.0$25.55
Logos Global Management LPTenPercentOwner2020-10-30Purchase15,000.0$26.17
Logos Global Management LPTenPercentOwner2020-10-30Sale27.0$27.02
Logos Global Management LPTenPercentOwner2020-10-30Purchase12,942.0$25.88
Logos Global Management LPTenPercentOwner2020-10-30Sale12,942.0$26.64
Logos Global Management LPTenPercentOwner2020-10-30Purchase15,000.0$26.48
Logos Global Management LPTenPercentOwner2020-10-30Purchase4,000.0$25.97
Logos Global Management LPTenPercentOwner2020-10-30Purchase31,000.0$24.53
Logos Global Management LPTenPercentOwner2020-10-30Purchase5,000.0$24.03
TURKEL CATHERINE C.President2019-05-21Sale1,914.0$1.91
Kuwahara JonSee Remarks2019-05-21Sale1,058.0$1.91
FLESHER GREGORY J.Chief Executive Officer2019-05-21Sale2,937.0$1.91
TURKEL CATHERINE C.President2019-05-20Sale7,623.0$1.96
Kuwahara JonSee Remarks2019-05-20Sale4,218.0$1.96
FLESHER GREGORY J.Chief Executive Officer2019-05-20Sale11,701.0$1.96
OrbiMed Israel GP Ltd.Director,TenPercentOwner2019-05-02Purchase646,204.0$3.1
OrbiMed Israel BioFund GP Limited PartnershipDirector,TenPercentOwner2019-05-02Purchase646,204.0$3.1
Chimovits ErezDirector2019-05-02Purchase646,204.0$3.1
LIFESCI INDEX PARTNERS LLCTenPercentOwner2019-04-30Sale200.0$2.7
YOOK PAULTenPercentOwner2019-04-30Sale200.0$2.7
TURKEL CATHERINE C.President2018-09-12Purchase16,632.0$5.02
TURKEL CATHERINE C.President2018-09-11Purchase17,048.0$4.56
TURKEL CATHERINE C.President2018-09-05Purchase805.0$3.97
FLESHER GREGORY J.Chief Executive Officer2017-05-10Purchase58,959.0$9.99
TURKEL CATHERINE C.Chief Development Officer2017-05-10Purchase11,111.0$9.99
OCAMPO CHRISTINESee Remarks2017-05-10Purchase10,010.0$9.99
Buckley Stephen Jr.Director2016-03-15Purchase8,000.0$5.74
Buckley Stephen Jr.Director2015-11-11Purchase3,000.0$11.25
McBride John S.Chief Operating Officer2015-09-21Sale13,500.0$14.01
Kalowski LeeChief Financial Officer2015-09-08Sale4,668.0$13.13
Kalowski LeeChief Financial Officer2015-09-02Sale2,158.0$12.96
Morrison Jodie PopePresident and CEO2015-07-29Sale564.0$13.7
Morrison Jodie PopePresident and CEO2015-07-28Sale12,000.0$13.7